COMMUNIQUÉS West-GlobeNewswire

PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus
15/04/2024
The study plans for the enrolment of 12 patients in 5 French clinical centers First study results expected in Q3 2024 This study will enable an evaluation of the intravenous administration of phages, particularly [...]
PHAXIAM Therapeutics annonce le recrutement du premier patient dans l’étude de phase 1 dans l’endocardite infectieuse causée par le Staphylococcus aureus
15/04/2024
L’étude prévoit l’inclusion de 12 patients dans 5 centres cliniques français Les premiers résultats sont attendus au 3 ème trimestre 2024 Cette étude permet d’évaluer l’administration intraveineuse des phages, [...]
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study
15/04/2024
Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in overall survival for people with relapsed or refractory diffuse large B-cell lymphoma Data from the STARGLO study will [...]
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
15/04/2024
Oslo, April 15, 2024: In connection with the Annual General Meeting of Ultimovacs ASA to be held on April 18, 2024, Jónas Einarsson, Chair of the Board of Directors, has so far received proxy based voting rights without [...]
Nxera Pharma Announces Exclusive Supply and Distribution Agreement with Handok for PIVLAZ™ in South Korea
15/04/2024
PIVLAZ™ is the first drug approved in South Korea for the prevention of Cerebral Vasospasm in patients with Aneurysmal Subarachnoid Hemorrhage (aSAH) PIVLAZ™ will become commercially available in South Korea in early [...]
Mobile-health Network Solutions Announces Closing of Initial Public Offering
13/04/2024
SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (“MNDR ” or “the Company ”), a leading telehealth solutions provider in Singapore, today announced the closing of its previously announced [...]
Biomerica Reports Third Quarter 2024 Financial Results
13/04/2024
Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented at the Upcoming [...]
American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione
13/04/2024
SAN FRANCISCO, April 12, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced [...]
Better Choice Company, Inc. Announces Fourth Quarter and Full Year 2023 Results
12/04/2024
Gross Margin Improved 300 basis points to 31% Year-Over-Year Adjusted EBITDA Grew 30% Year-Over-Year EPS Grew 45% Year-Over-Year TAMPA, Fla., April 12, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American [...]
Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients with Angelman Syndrome
12/04/2024
Conference call now scheduled for Monday, April 15 at 8:00 a.m. ET Updated registration link below NOVATO, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that [...]
International Myeloma Foundation Celebrates ODAC Meeting Outcome on Minimal Residual Disease (MRD) Testing as an Early Endpoint for the Accelerated Approval of Myeloma Drugs in Clinical Trials: A Huge Win for the Global Myeloma Community
12/04/2024
This conclusion is the result of almost 10 years of research carried out by the International Myeloma Foundation STUDIO CITY, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is [...]
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
12/04/2024
WOODCLIFF LAKE, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Notice”) on April 8, 2024 from the Listing [...]
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
12/04/2024
WARREN, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' [...]
Sanofi: Information concerning the total number of voting rights and shares - March 2024
12/04/2024
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mars 2024
12/04/2024
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Nexstim Plc Resolved on a New Stock Option Plan 2024H
12/04/2024
Company Announcement, Helsinki, 12 April 2024 at 9 PM (EEST) Nexstim Plc Resolved on a New Stock Option Plan 2024H Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces that the Board of Directors of Nexstim [...]
MEDIA ADVISORY: Press conferences with patients who have been charged user fees of hundreds or even thousands of dollars at for-profit surgery clinics
12/04/2024
TORONTO and LONDON and WATERLOO and BRAMPTON, Ontario, April 12, 2024 (GLOBE NEWSWIRE) -- Patients are being threatened with extremely long wait times, denied vital procedure information, and coerced or manipulated into [...]
Ontario Psychological Association Unveils New Mental Health Insights - Report
12/04/2024
TORONTO, April 12, 2024 (GLOBE NEWSWIRE) -- The Ontario Psychological Association (OPA) today released a pivotal report, “ Mental Health in Ontario: Insights from AskForHelpToday.ca ,” based on an analysis of over 12, [...]
Intermountain McKay Dee Hospital and Intermountain Medical Center Named to Fortune's 2024 Top 50 Heart Hospitals List
12/04/2024
SALT LAKE CITY and OGDEN, Utah, April 12, 2024 (GLOBE NEWSWIRE) -- Two Intermountain Health facilities have been named 2024 Top 50 Heart Hospitals in the U.S. by Fortune Magazine. Intermountain McKay-Dee Hospital in [...]

Pages